Latest news
Loading news…
Ganymed Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Mainz, Rheinland-Pfalz, Germany Founded 2001 11-50 employees For Profit
Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.
Ganymed Pharmaceuticals was acquired by Astellas Pharma in 2016 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
31
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 5
- Patents granted
- 31
- Trademarks
- 0
- Top patent class
- Organic Chemistry
Company Info
- Founded
- 2001
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 12
- HQ
- Mainz, Rheinland-Pfalz, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Oct 28, 2016
- Closed
- Mar 22, 2017
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -1.1
- Trend (90d)
- 1.5
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ganymed Pharmaceuticals
Loading news…
FAQs about Ganymed Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.